USA - NYSEARCA:CPHI - US16941T4013 - Common Stock
The current stock price of CPHI is 1.776 USD. In the past month the price decreased by -8.26%. In the past year, price decreased by -30.76%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 50.37 | 769.97B | ||
| JNJ | JOHNSON & JOHNSON | 17.98 | 449.40B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.52 | 254.96B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.47 | 235.79B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.21 | 228.26B | ||
| MRK | MERCK & CO. INC. | 11.24 | 216.26B | ||
| PFE | PFIZER INC | 7.17 | 138.10B | ||
| SNY | SANOFI-ADR | 11.47 | 123.51B | ||
| GSK | GSK PLC-SPON ADR | 10.3 | 92.38B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.33 | 86.71B | ||
| ZTS | ZOETIS INC | 23.14 | 63.79B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 49.18 | 43.49B |
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 224 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
CHINA PHARMA HOLDINGS INC
2nd Floor, No. 17, Jinpan Road, Haikou
Haikou HAINAN 570216 CN
CEO: Zhilin Li
Employees: 224
Phone: 8689866811730
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 224 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
The current stock price of CPHI is 1.776 USD. The price increased by 0.91% in the last trading session.
CPHI does not pay a dividend.
CPHI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
CHINA PHARMA HOLDINGS INC (CPHI) currently has 224 employees.
ChartMill assigns a technical rating of 2 / 10 to CPHI. When comparing the yearly performance of all stocks, CPHI is a bad performer in the overall market: 82.94% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to CPHI. CPHI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months CPHI reported a non-GAAP Earnings per Share(EPS) of -1.58. The EPS increased by 74.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.56% | ||
| ROE | -56.58% | ||
| Debt/Equity | 0.53 |